SMAD4 and pancreatic neoplasm: Stable Smad4 reexpression in colorectal and pancreatic cancer cells was adequate to mediate tumour suppression in vivo, did not inhibit cell growth in vitro and was not sufficient to rescue TGF-β antiproliferative responses.